Compass Wealth Management’s Labcorp LH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-1,379
Closed -$396K 116
2025
Q3
$396K Hold
1,379
0.09% 118
2025
Q2
$362K Hold
1,379
0.09% 121
2025
Q1
$321K Hold
1,379
0.08% 127
2024
Q4
$316K Hold
1,379
0.08% 133
2024
Q3
$308K Hold
1,379
0.07% 138
2024
Q2
$281K Hold
1,379
0.07% 138
2024
Q1
$301K Buy
1,379
+67
+5% +$14.8K 0.08% 134
2023
Q4
$298K Sell
1,312
-457
-26% -$96K 0.08% 132
2023
Q3
$356K Sell
1,769
-552
-24% -$116K 0.11% 120
2023
Q2
$481K Sell
2,321
-72
-3% -$14K 0.15% 114
2023
Q1
$472K Sell
2,393
-189
-7% -$38.9K 0.15% 117
2022
Q4
$522K Buy
+2,582
New +$505K 0.17% 112

Other funds holding LH

Compass Wealth Management's LH Position: Q4 2025 in Review

Compass Wealth Management sold out of Labcorp (LH) in Q4 2025, closing a stake of 1,379 shares — an estimated $396K sold.

Compass Wealth Management first reported a position in LH in Q4 2022 and held it in 12 quarters. The position peaked at $522K in Q4 2022. 1,024 funds tracked by Wall St. Rank hold LH as of Q4 2025.

  • Compass Wealth Management reported no remaining Labcorp position as of Q4 2025 after selling out during the quarter.
  • Compass Wealth Management sold 1,379 Labcorp shares in Q4 2025, an estimated $396K.
  • Compass Wealth Management first reported a position in Labcorp in Q4 2022 and held it in 12 quarters.
  • Compass Wealth Management's Labcorp position peaked at $522K in Q4 2022.
  • 1,024 funds tracked by Wall St. Rank held Labcorp as of Q4 2025.

Based on Compass Wealth Management's 13F filing for Q4 2025, filed 11 Feb 2026.